CC what you didn't read the results properly then? OK read these three sentences again!
I believe this recent licensing activity in EiRx's chosen field bodes well for
EiRx's future prospects, but also indicates the stage of development at which
the Company can expect to secure a significant license deal.
To reach the late preclinical stage common to the recent license deals listed above, EiRx will require a MINIMUM of two to three years' further research and development. We have deliberately structured our drug discovery programme to ensure that multiple projects will be available for further development by the Company over this timeframe, to hedge against the risk of failure of one or more projects.
Esp, I don't want to start making predictions. That 8p business is really according to the company something like 4p-20p!
Milestones payments and some sort of devopment news is obviously gonna send things here up alot. No idea about how high the spike will be. But we can relax that someone will make sure the spike is as high as poss!.